SC
TARS icon

Steven Cohen’s Tarsus Pharmaceuticals TARS Stock Holding History

Steven Cohen’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-226,251
Closed -$15.9M – 4573
2026
Q1 		$15.9M Buy
226,251
+188,623
+501% +$13.2M 0.02% 941
2025
Q4 		$3.08M Buy
+37,628
New +$2.81M ﹤0.01% 2187
2024
Q1 		– Sell
-19,575
Closed -$396K – 2604
2023
Q4 		$396K Sell
19,575
-79,725
-80% -$1.33M ﹤0.01% 1642
2023
Q3 		$1.76M Buy
+99,300
New +$1.76M 0.01% 1174

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steven Cohen's TARS Position: Q2 2026 in Review

Steven Cohen sold out of Tarsus Pharmaceuticals (TARS) in Q2 2026, closing a stake of 226,251 shares — an estimated $15.9M sold.

Steven Cohen first reported a position in TARS in Q3 2023 and held it in 4 quarters. The position peaked at $15.9M in Q1 2026. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Steven Cohen reported no remaining Tarsus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 226,251 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $15.9M.
  • Steven Cohen first reported a position in Tarsus Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • Steven Cohen's Tarsus Pharmaceuticals position peaked at $15.9M in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.